Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen, Luxembourg Biobank Partner on Molecular Signatures

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen BioSystems today said that it will collaborate with the Integrated BioBank of Luxembourg to co-develop molecular signatures for diagnostic research and commercial applications.

Fremont, Calif.-based WaferGen said that IBBL will purchase a SmartChip Real-Time PCR system and use it to discover and validate gene expression patterns. It added that the partners plan to file for approval in Europe of the molecular signatures.

In addition, they will pursue a research partnership in cancer and other areas of interest and will offer SmartChip Gene-Expression Profiling services in Europe using WaferGen's system.

WaferGen Chairman and CEO Alnoor Shivji said the alliance "enables WaferGen to access best-annotated patient samples for future diagnostic products. It also establishes a beach-head in Europe to unlock the short- and long-term revenue potential of the WaferGen SmartChip system."

The company also said that it will establish its European Headquarters at the IBBL facilities in the very near future.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.